DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Cloudflare - 1 Dow - 1 Jerome Powell - 1 Sonu Varghese - 1 payrolls - 1 Dow Jones - 1 Adam Parker - 1 Parker - 1
Top related locs:
New York City U.S — China Monday's
Top related orgs:
New York Stock Exchange - 1 Stock - 1 Dow Jones Industrial - 1 Nasdaq - 1 Apple - 1 Biotech Amgen - 1 Dow - 1 Carson Group - 1

Search resuls for: "Biotech Amgen"


3 mentions found


☆ Stock futures rise after Apple reports, traders look to April payrolls data: Live updates
  + stars: | 2024-05-02 | by ( Pia Singh | ) www.cnbc.com   time to read: +2 min
Futures tied to the Dow Jones Industrial Average gained 212 points, or 0.55%. S&P 500 futures rose nearly 0.3%, while Nasdaq 100 futures advanced about 0.5%. In extended trading, Apple advanced more than 6% after it announced a $110 billion share repurchase and a top -and bottom-line beat. The S&P 500 popped 0.91%, while the Dow gained 0.85%. The S&P 500 is off by 0.7% week to date, while the Nasdaq is down nearly 0.6%.
Persons: Cloudflare, Dow, Jerome Powell, Sonu Varghese, payrolls, Dow Jones Organizations: New York Stock Exchange, Stock, Dow Jones Industrial, Nasdaq, Apple, Biotech Amgen, Dow, Carson Group Locations: New York City, U.S
☆ These stocks may have trouble living up to expectations for a big earnings turnaround this year
  + stars: | 2024-03-26 | by ( Pia Singh | ) www.cnbc.com   time to read: +3 min
This in effect creates an 'implied' 2H of 2024 guidance that is perhaps excessively optimistic," CEO Adam Parker wrote Sunday. Parker's warning comes after S & P 500 reported earnings growth of 4.2% for the fourth quarter on a year-over-year basis, per FactSet. He also screened for stocks in which there's a big difference between earnings expectations for the first and the second half of the year. Parker surmises that these stocks may disappoint on these aggressive earnings turnarounds. Consensus estimates from analysts surveyed by FactSet suggest the stock, which is down nearly 5% this year, could gain 13.2% from Monday's close.
Persons: Adam Parker, Parker, AbbVie, FactSet, Wells Fargo, Estee Lauder Organizations: Research, Abbott Laboratories, Humana, Pharmaceutical, FactSet, Mondelez International, Procter, Gamble Locations: —, China, Monday's
☆ Drug companies favor biotech meds over pills, citing new U.S. law
  + stars: | 2023-01-13 | by ( Deena Beasley | ) www.reuters.com   time to read: +5 min
The pharmaceutical industry, whose members gathered in the thousands this week in San Francisco for the annual JP Morgan Healthcare conference, opposed the legislation and has begun implementing strategies to mitigate its impact. "In 10 years, we'll have far fewer small molecules being developed than we do today." He questioned the benefit of "rules that really just disincentivize investment in what ends up being convenient drugs, drugs for tough conditions like cancer and drugs that get really cheap when they go generic." Most medicines on the market today are small molecules, which can be taken by mouth, absorbed into the bloodstream and easily penetrate cell membranes. He noted it is not unusual for pharmaceutical companies to choose not to pursue a drug they once thought promising.
0 next >>
Total: 3